secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inhibitor Therapeutics, Inc. (INTI)
CIK:        0001042418
Form:       8-K
Filed at:   2022-06-03T23:59:59+00:00
Accession:  0001193125-22-167340
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Debra Peattie retires from Inhibitor Therapeutics Board
----------------------------------------------------------------

- Debra Peattie retired from Board effective June 1, 2022, to focus on other professional opportunities.
- Retirement is not based on any disagreement with the company's operations, policies, or practices.
- Compensation Committee determined Peattie retired in good standing; vested options may be held for full term.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1042418/000119312522167340/0001193125-22-167340-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1042418/000119312522167340/d316736d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-167340

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer